American Conference Institute (ACI) will be holding the West Coast Edition of its Advanced Forum on Life Sciences Collaborative Agreements and Acquisitions from July 20-21, 2011 in San Francisco, CA. The conference will allow attendees to:
• Position their companies in light of emerging trends in deal structuring and increasing M&A activity;
• Optimize business development strategies by incorporating the key takeaways from recent life sciences deals;
• Structure option deals including multiple staged acquisitions and hybrid deals to meet both parties' objectives;
• Negotiate milestone payments and other essential critical terms to maximize profitability;
• Raise capital by cultivating lucrative relationships with key industry players including universities, research institutions, non-profits, and government organizations;
• Strengthen market power and bargaining position through an effective due diligence analysis;
• Protect assets and minimize risk by including critical termination provisions;
• Forge strategic alliances to facilitate continued growth and sustainability in emerging markets; and
• Maintain effective alliance management to ensure mutually beneficial influx of capital and resources.
In particular, ACI's faculty will offer presentations on the following topics:
• Market watch: Understanding the driving forces and changing dynamics impacting the current deal-making landscape;
• Integrating increasing M&A activity into your business development strategy;
• Best practices for selecting the deal structure and negotiating your most beneficial collaborative agreement yet;
• Negotiating options, staged acquisitions, hybrid transactions and straight-forward M&As;
• Streamlining entry into lucrative emerging markets via strategic partnering;
• Beyond the shadow of the valley: Alternative pathways and partnerships to facilitate funding drug discovery and development;
• Preparing for the exit: Proactively drafting critical termination provisions to protect company assets;
• Protecting current and future collaborations: The do's and don'ts of partnering / negotiations;
• Aligning divergent interests to negotiate mutually beneficial collaborative research agreements with academic institutions;
• Utilizing applicable valuation models to set realistic expectations for a deal;
• Mitigating legal risks in the life sciences M&A setting: A six-step approach; and
• Licensing strategies for biosimilars: Regulatory, commercial and IP considerations for the new frontier.
A post-conference master class, entitled "Life Sciences IP Due Diligence Boot Camp: Conducting Effective & Strategic Due Diligence for Life Science Partnering and M&A," will be offered on July 22, 2011. In this workshop, ACI faculty will offer presentations on the following topics:
• Spotting red flags that impact the value and success of a life sciences transaction;
• Factoring recent relevant IP developments into your due diligence analysis: Biosimilars, Myriad, Prometheus, and more -- to be presented in part by Patent Docs author Dr. Donald Zuhn;
• Properly aligning the business objective of the deal and the IP diligence assessment: An interactive checklist;
• Evaluating the scope, breadth, validity and enforceability of the target's patents under evolving patent standards and regulatory protocols;
• Who invented what when? Reducing and resolving inventorship disputes; and
• Ensuring that the purchaser/licensee has the right to commercialize the IP at issue.
The agenda for the Life Sciences Collaborative Agreements and Acquisitions conference can be found here. A complete brochure for this conference, including an agenda, detailed descriptions of conference sessions, list of speakers, and registration form can be obtained here.
The registration fee for the conference is $2,295 (conference alone), $3,095 (conference and master class), or $1,395 (master class alone). Those registering by May 20, 2011 will receive a $300 discount off the conference alone or conference and master class, and those registering by June 24, 2011 will receive a $200 discount off the conference alone or conference and master class. Those interested in registering for the conference can do so here, by calling 1-888-224-2480, or by faxing a registration form to 1-877-927-1563.
Patent Docs is a media partner of ACI's Life Sciences Collaborative Agreements and Acquisitions conference.
Comments